SP140: A Protein Involved in Immune Function and Disease Development

Target Name: SP140

NCBI ID: G11262

SP140

SP140: A Protein Involved in Immune Function and Disease Development

SP140 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the T-cell receptor signaling pathway, which is involved in the regulation of immune responses and inflammation.

SP140 has been identified as a potential drug target due to its involvement in the regulation of immune cell function and its expression in a variety of diseases, including cancer. Additionally, SP140 has been shown to play a role in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

SP140 is a key regulator of the T-cell receptor signaling pathway, which is a critical pathway involved in the regulation of immune cell function. The T-cell receptor is a protein that is expressed in T cells, which are a type of immune cell that play a critical role in the regulation of the immune system. The T-cell receptor signaling pathway is involved in the regulation of T-cell growth, differentiation, and function, and is important for the development and maintenance of a strong immune response to infections and diseases.

SP140 is a key regulator of the T-cell receptor signaling pathway. It is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. SP140 plays a role in the regulation of immune cell function and has been shown to be involved in the development and maintenance of a strong immune response.

SP140 has been shown to play a role in the regulation of immune cell function and its expression in a variety of diseases, including cancer. For example, studies have shown that high levels of SP140 are associated with poor prognosis in patients with pancreatic cancer, a type of cancer that is characterized by the formation of tumors in the pancreas, a gland located behind the stomach that produces hormones and digestive enzymes. Additionally, SP140 has been shown to be involved in the regulation of the immune response to viruses, including the flu virus, which can lead to the development of flu-like symptoms.

SP140 has also been shown to play a role in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. These conditions are characterized by the progressive loss of brain cells and are associated with a range of symptoms, including cognitive decline and behavioral changes. SP140 has been shown to be involved in the regulation of the immune response to neurodegenerative diseases and has been shown to play a role in the development and progression of these conditions.

In conclusion, SP140 is a protein that is involved in the regulation of immune cell function and has been identified as a potential drug target due to its involvement in the development and maintenance of a strong immune response. Studies have shown that high levels of SP140 are associated with poor prognosis in patients with pancreatic cancer and are involved in the regulation of the immune response to viruses, as well as the development and progression of neurodegenerative diseases. Further research is needed to fully understand the role of SP140 in these processes and to determine its potential as a drug target.

Protein Name: SP140 Nuclear Body Protein

Functions: Component of the nuclear body, also known as nuclear domain 10, PML oncogenic domain, and KR body (PubMed:8910577). May be involved in the pathogenesis of acute promyelocytic leukemia and viral infection (PubMed:8910577). May play a role in chromatin-mediated regulation of gene expression although it does not bind to histone H3 tails (PubMed:24267382)

The "SP140 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SP140 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets